Upgrade to SI Premium - Free Trial

Lipocine (LPCN)

2.14 +0.06 (2.88%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Form 4 Lipocine Inc. For: Jun 29 Filed by: Patel Mahesh V. June 30, 2026 7:31 PM - SEC Filing Form 8-K Lipocine Inc. For: Jun 12 June 12, 2026 4:07 PM - SEC Filing Form S-8 Lipocine Inc. June 9, 2026 4:06 PM - SEC Filing Form 8-K Lipocine Inc. For: Jun 03 June 4, 2026 4:06 PM - SEC Filing Form 4 Lipocine Inc. For: Jun 03 Filed by: Jene Jill M. June 4, 2026 4:06 PM - SEC Filing Form 4 Lipocine Inc. For: Jun 03 Filed by: Higuchi John W. June 4, 2026 4:06 PM - SEC Filing Form 4 Lipocine Inc. For: Jun 03 Filed by: Ono Richard Dana June 4, 2026 4:06 PM - SEC Filing Form 8-K Lipocine Inc. For: Jun 04 June 4, 2026 9:00 AM - SEC Filing Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154 June 4, 2026 8:00 AM - PR NewsWire Form 8-K Lipocine Inc. For: May 26 May 26, 2026 5:08 PM - SEC Filing Form 8-K Lipocine Inc. For: May 19 May 19, 2026 9:00 AM - SEC Filing Lipocine phase 3 data for LPCN 1154 accepted for ASCP meeting presentation May 19, 2026 8:01 AM - StreetInsider Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting May 19, 2026 8:00 AM - PR NewsWire Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer May 19, 2026 4:00 AM - StreetInsider Form 8-K Lipocine Inc. For: May 18 May 18, 2026 9:00 AM - SEC Filing Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase May 18, 2026 8:01 AM - PR NewsWire Form SCHEDULE 13G Lipocine Inc. Filed by: Ikarian Capital, LLC May 15, 2026 5:05 PM - SEC Filing Form SCHEDULE 13G/A Lipocine Inc. Filed by: Squadron Capital Management LLC May 15, 2026 11:56 AM - SEC Filing Lipocine (LPCN) Misses Q1 EPS by 54c May 7, 2026 6:18 PM - StreetInsider Form 8-K Lipocine Inc. For: May 07 May 7, 2026 4:11 PM - SEC Filing Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026 May 7, 2026 4:05 PM - PR NewsWire Form 8-K Lipocine Inc. For: May 07 May 7, 2026 9:05 AM - SEC Filing Form 10-Q Lipocine Inc. For: Mar 31 May 7, 2026 9:01 AM - SEC Filing Full Article List